202  Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis.

201  Treatment of female Anopheles gambiae mosquitoes with atovaquone causes arrest of the Plasmodium falciparum parasite in the midgut, and this holds promise for malaria eradication in areas with insecticide-resistant mosquito populations.

200  Paper-based microfluidics for DNA diagnostics of malaria in low resource underserved rural communities.

199  IPSE, a urogenital parasite-derived immunomodulatory protein, ameliorates ifosfamide-induced hemorrhagic cystitis through downregulation of pro-inflammatory pathways.

198  AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis.

197  Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.

196  Improved reference genome of Aedes aegypti informs arbovirus vector control.

195  Serotonin signaling regulates insulin-like peptides for growth, reproduction, and metabolism in the disease vector Aedes aegypti.

194  Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.

193  Larvae of the parasitic helminth Heligmosomoides polygyrus induce granuloma formation and a fetal-like developmental program in granuloma-associated crypts of infected adult mice.

Free Images for Presentation: sunipix SUNIPIX